REPORT HIGHLIGHT
Direct-to-Consumer Genetic Testing Market size was valued at USD 3,107.8 Million in 2022, expanding at a CAGR of 12.8% from 2023 to 2030.
Direct-to-Consumer Genetic Testing offers online or over-the-counter access to genetic information without healthcare providers. This type of genetic testing can provide information on ancestry, disease risk, carrier status for problems that could be passed down to children, trait reports, and more. Many companies now provide direct-to-consumer genetic tests for a variety of reasons. The most popular tests use a small collection of genetic variations to predict specific aspects of health, provide information about typical traits, and provide ancestry information. Another technology that is becoming more popular in DTC genetic tests is genome sequencing. These tests sequence nearly the whole genetic code and discover variants within it.
Direct-to-Consumer Genetic Testing Market- Market Dynamics:
- The rising prevalence of genetic disorders is expected to propel the market growth.
- The increasing prevalence of genetic illnesses around the world has raised the demand for genetic testing, especially DTC genetic testing. The increasing prevalence of genetic illnesses has raised public awareness of these conditions and the possible significance of genetics in health. Individuals are seeking to understand their genetic risk for particular disorders, which is boosting demand for DTC genetic testing. World Health Organization estimates that Genetic disorders and congenital abnormalities occur in about 2%-5% of all live births, accounting for up to 30% of pediatric hospital admissions, and cause about 50% of childhood deaths in industrialized countries. The national center for biotechnology information estimated 495,000 infants with congenital malformations, 390,000 with G6PD deficiency, 21,400 with Down syndrome, 9,000 with beta-thalassemia, 5,200 with sickle cell disease, and 9,760 with amino acid disorders are born each year. Advances in genomics and genetic testing technology can make tests more accurate, inexpensive, and accessible, opening up new opportunity for expansion in the DTC genetic testing business. However, the high pricing model of DTC Kits and privacy corns restrains the market growth.
Direct-to-Consumer Genetic Testing Market- Key Insights:
- As per the analysis shared by our research analyst, the global Direct-to-Consumer Genetic Testing market is estimated to grow annually at a CAGR of around 12.8% over the forecast period (2023-2030)
- The Direct-to-Consumer Genetic Testing industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
- Based on test type segmentation, Predictive Testing was predicted to show maximum market share in the year 2022
- Based on Technology segmentation, Whole Genome Sequencing was the leading type in 2022
- Based on Distribution channel segmentation, Online Platforms were the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Direct-to-Consumer Genetic Testing Market- Segmentation Analysis:
- The Global Direct-to-Consumer Genetic Testing Market is segmented on the basis of test Type, Technology, Distribution channel, and Region.
- The market is divided into three categories based on test type: Nutrigenomics Testing, Predictive Testing, Carrier Testing, and Others. Predictive Testing is a sector that dominates the market. Predictive testing is a type of genetic testing that can detect genetic changes linked to problems that develop after birth, generally later in life. These tests can help determine the chance of developing specific disorders such as cancer, heart disease, and Alzheimer's disease.
- The market is divided into three categories based on Technology: Whole Genome Sequencing, Single Nucleotide Polymorphism Chips, Targeted Analysis, and Others. Whole Genome Sequencing dominates the market and is likely to maintain its dominance during the forecast period. Whole genome sequencing (WGS) is a comprehensive method for studying complete genomes. It requires identifying the entire DNA sequence of an organism's genome all at once.
- The market is divided into two categories based on Distribution channels: Online Platforms and Over the Counter. Online Platforms dominate the market. The majority of DTC genetic testing companies mainly operate through online platforms. Consumers can obtain test kits online, ship in their samples, and then access their results online, often through a secure portal or a downloadable report.
Direct-to-Consumer Genetic Testing Market- Geographical Insights:
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the market. North American region increased frequency of genetic illnesses such as hemophilia, Alzheimer's disease, cystic fibrosis, sickle cell disease, and numerous malignancies raises the demand for genetic testing. This demand drives growth in the DTC genetic testing industry as people seek to understand their hereditary risks and potential remedies. Alzheimer's Association stated that More than 6 million Americans are living with Alzheimer's. By 2050, this number is projected to rise to nearly 13 million. Furthermore, the Europe region may provide growth opportunities in the forecast period, due to increasing public awareness of DTC genetic testing.
Direct-to-Consumer Genetic Testing Market- Competitive Landscape:
The market for direct-to-consumer genetic testing is expanding rapidly. This expansion can be ascribed to causes such as increased awareness of genetic illnesses, genomic advancements, and the growing trend of personalized therapy. Consumers' curiosity about their genetic makeup, background, and potential health hazards also promotes the business. Companies compete primarily on aspects such as the breadth of tests offered, test accuracy, pricing, the comprehensibility of the results presented to consumers, and additional features such as genetic counseling or tools for family tree development. Manufacturers focused on a strategy to collaborate with healthcare providers and employers, promote clinical-grade tests, and provide genetic counselor support. for example, In April 2017, however, the U.S. Food and Drug Administration (FDA) gave genetics company 23andMe the go-ahead to sell DNA tests assessing the user's level of risk for ten health conditions, including Parkinson's disease and late-onset Alzheimer's disease.
Recent Developments:
On 03 April 2020, Genesis Healthcare Co., Japan's leading genetic testing and research company, nowadays announced the launch of a real-time PCR-based (Polymerase Chain Reaction) detection test kit for SARS-CoV-2 the novel coronavirus that causes COVID-19. This new test kit will be available for healthcare providers and corporate organizations to accelerate early detection in Japan.
Key features of the study:
- This proposed research study on Direct-to-Consumer Genetic Testing market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
- The report provides the client the latest up-to-date and trending insights about the Direct-to-Consumer Genetic Testing market.
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Direct-to-Consumer Genetic Testing market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Direct-to-Consumer Genetic Testing market
- Impact of COVID-19 on Direct-to-Consumer Genetic Testing market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Direct-to-Consumer Genetic Testing market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the Direct-to-Consumer Genetic Testing market, we have also included competitive landscape and key innovator analysis for the Direct-to-Consumer Genetic Testing market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Direct-to-Consumer Genetic Testing market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global Direct-to-Consumer Genetic Testing market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET KEY PLAYERS
- Family Tree DNA
- Ancestry
- Genesis HealthCare
- EasyDNA,
- Veritas
- Myriad Genetics Inc.
- Full Genomes Corporation, Inc
- Living DNA Ltd.
- Color Health, Inc.
GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET, BY TEST TYPE
- Nutrigenomics Testing
- Predictive Testing
- Carrier Testing
- Others
GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET, BY TECHNOLOGY
- Whole Genome Sequencing
- Single Nucleotide Polymorphism Chips
- Targeted Analysis
- Others
GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET, BY DISTRIBUTION CHANNEL
- Online Platforms
- Over The Counter
GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA